Malta Life Sciences Cluster
Life Sciences Centre
Mater Dei Hospital
University of Malta
MaltaEnterprise
1
National Economic Rationale
1.
A shift in the type of investment attracted to Malta
from a low cost – low value to medium/high end - high
value added
2.
Increased demand for laboratory infrastructures to:
3.
Test-run new products
Validation tests for prototypes
Electromagnetic testing
Sterilisation testing
A thriving Life Sciences industry
Pharmaceuticals
Medical Devices
MaltaEnterprise
2
International Rationale
1.
Western countries have an ageing population
2.
Most companies are start-ups
3.
Higher demand for more advanced medical treatments and
technologies, generating a reliable, growing income for
healthcare companies.
Typically dependent on one or two unproven (and often
undeveloped) products.
Perennially thirsty for finance to bring them to market.
A handful will spring into life, most will be quietly interred
with their investors' money.
Double digit earnings growth forecast
Improving fundamentals, pipeline progress, potential M&A
upward earnings per share revisions are likely to benefit
future share price growth.
MaltaEnterprise
3
LSC - Malta
Fully serviced high quality campus
setting:
10,000m2 State-of-the-art Life Sciences
Centre at the heart of the Park
3,500m2 Business Incubation Centre
with active management assisting high
growth business
Business Advisory Services
Fiscal and Financial Incentives
Strong and lasting tangible support
from Government, Malta Enterprise
and the business community
Close ties and collaboration with
university, hospital and research
institutions
A can do attitude
MaltaEnterprise
4
Tenant Mix
Research institutes and industry research facilities
Spin-out and start-up technology based firms
Life sciences companies in all phases of development from startups to multinationals
Small, highly specialised value chain parts of large companies
Advanced medical research clinics
Education and workforce technical training centres
Formulation and testing companies
Support services – legal, venture capital, marketing…
MaltaEnterprise
5
Location
SITE
HOSPITA
L
UNIVERSIT
Y
Master Plan Architecture Projects
LOCATION
MaltaEnterprise
6
Location
SITE
HOSPITA
L
UNIVERSIT
Y
Master Plan Architecture Projects
LOCATION
MaltaEnterprise
7
LSC Plan
LS3
LS4
LS2
LS1
MaltaEnterprise
8
LSC Plan
MaltaEnterprise
9
LS1 and LS2 Plan
MaltaEnterprise
10
LS1 Plan
MaltaEnterprise
11
LSC Concept
LS3
LS1
LS4
LS2
Master Plan Architecture Projects
MaltaEnterprise
12
LS1 Spaces
4 units - 24 sqm
6 units - 63-67 sqm
11 units - 71-78 sqm
6 units - 206-223 sqm
6 floors + Underground
27 Units
Total 2612 sqm
MaltaEnterprise
13
LS2 Spaces
16 units 55-60sqm
10 units 114-226 sqm
1 unit 386 sqm
2 floors + underground
27 units
Total 3191 sqm
MaltaEnterprise
14
LS1 & LS2 Spaces
MaltaEnterprise
15
LS3 Spaces
2 units 39-50 sqm
12 units 161-234 sqm
1 unit 700sqm (Level -1)
2 floors + Underground
15 units
Total 3163 sqm
MaltaEnterprise
16
LS3 Spaces
MaltaEnterprise
17
LSC Plan – Cyclotron Option
MaltaEnterprise
18
LSC Plan – Cyclotron Option
MaltaEnterprise
19
LSC Plan – Cyclotron Option
MaltaEnterprise
20
LS4 Spaces
500 sqm Conference Hall seating 150-200 including
backstage, interpreters’ room,
500 sqm Lobby Area with cafeteria, meeting rooms, exhibition
space and convenience outlet
MaltaEnterprise
21
LS4 Spaces
MaltaEnterprise
22
LS4 Spaces
MaltaEnterprise
23
Best Practice
MaltaEnterprise
24
LSC Activities Interrelation
Foreign
Clients
Expert Group
MRI head
Foreign
Clients
Local
Hospitals
PET
Scanner
for Clinical
Trials
Cyclotron
Uni Medical, Bio
& Chemistry
Departments
Medical
Imaging
Labs
BioElectronics
Labs
LSC
Pharma
Pharma
Process
Process
Dev.
Dev.Labs
Labs
BioInformatics
Labs
Clinical
Clinical
Trials
TrialsLab
Labs
Genomics
Expert
Center
Diagnostics
Diagnostics
&&Analytical
Analytical
Labs
Labs
Uni
BioBank
Uni IT &
Engineering
Departments
Alliance
Foreign
Pharma
Local
Pharma
Local
Clients
Foreign
Clients
Alliance
Medicines
Authority
MaltaEnterprise
25
Technical Consultants
Geoff Wainwright, PhD - Executive Director 2Bio Ltd.
Manages 2Bio’s business support programmes having established and
successfully managed the MerseyBIO Incubator since 2001 and
supporting more than 30 new start-up life science companies.
• The Merseybio Incubator is a state-of-the-art facility
– Current tenants Biofortuna Ltd
Bradford Pharma Ltd
Hydra Polymers Ltd
Insight Chemical Solutions Ltd
Intellihep Ltd
IOTA NanoSolutions Limited
Provexis IBD Ltd
SafeBridge Europe Ltd
MaltaEnterprise
26
ERDF 199: Setting up
a Life Science Centre
MaltaEnterprise
27